Which protocol could you recommend to activate a FLPo (integrated into the AAVS1 locus) with an ERT2 receptor by tamoxifen (4-OHT) in human iPSCs?

The problem with my protocol is the vastly increased cell death.

With what µM of 4-OHT would you start and proceed for how long to ensure cell survival as well as proper activation of the FLPo?

Thanks, for your help in advance!!

More Lisa Auinger's questions See All
Similar questions and discussions